These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17189202)

  • 21. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
    Kagiyama S; Matsumura K; Fukuhara M; Sakagami K; Fujii K; Iida M
    Hypertens Res; 2007 Oct; 30(10):979-89. PubMed ID: 18049031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XIIIA (cross)links AT1 receptors to atherosclerosis.
    Ogawa S; Glass CK
    Cell; 2004 Oct; 119(3):313-4. PubMed ID: 15507203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin AT2 receptor: the younger sibling attracts attention.
    Cerbai E; Mugelli A
    Cardiovasc Res; 2004 Apr; 62(1):7-8. PubMed ID: 15023548
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double trouble for type 1 angiotensin receptors in atherosclerosis.
    Thomas WG
    N Engl J Med; 2005 Feb; 352(5):506-8. PubMed ID: 15689592
    [No Abstract]   [Full Text] [Related]  

  • 28. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
    J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension.
    Efrati S; Berman S; Goldfinger N; Erez N; Averbukh Z; Golik A; Rotter V; Weissgarten J
    J Hypertens; 2007 May; 25(5):1041-52. PubMed ID: 17414669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Networking between systemic angiotensin II and cardiac mineralocorticoid receptors.
    Montezano AC; Touyz RM
    Hypertension; 2008 Dec; 52(6):1016-8. PubMed ID: 18981322
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertrophy and ventricular remodeling in systemic arterial hypertension: role of AT1 receptors].
    Troyo Barriga P
    Arch Cardiol Mex; 2003; 73 Suppl 1():S146-9. PubMed ID: 12966667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice.
    Kai T; Shimada S; Kurooka A; Takenaka T; Ishikawa K
    Blood Press; 1998 Jan; 7(1):61-3. PubMed ID: 9551879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?
    Zouein FA; Altara R; Massoud GP; Booz GW
    J Cardiovasc Pharmacol; 2021 May; 77(5):531-535. PubMed ID: 33657051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of activity of angiotensin I and II in the perfused heart and kidney.
    Ercan ZS; Türker RK; Bor MN
    New Istanbul Contrib Clin Sci; 1980 May; 13(2):80-94. PubMed ID: 7220253
    [No Abstract]   [Full Text] [Related]  

  • 35. In hypertension, the kidney breaks your heart.
    Crowley SD; Coffman TM
    Curr Cardiol Rep; 2008 Nov; 10(6):470-6. PubMed ID: 18950556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac energy metabolism alterations in angiotensin II induced hypertrophy.
    Lopaschuk GD
    J Mol Cell Cardiol; 2006 Sep; 41(3):418-20. PubMed ID: 16876818
    [No Abstract]   [Full Text] [Related]  

  • 37. In hypertension, the kidney is not always the heart of the matter.
    Mendelsohn ME
    J Clin Invest; 2005 Apr; 115(4):840-4. PubMed ID: 15841174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could AT1 receptor activation increase antioxidant defense to prevent salt-induced vascular dysfunction of 2 kidney-1 clip hypertensive rats?
    Braga VA
    Am J Hypertens; 2014 Apr; 27(4):638-9. PubMed ID: 24614862
    [No Abstract]   [Full Text] [Related]  

  • 39. Renin.
    Horwitz DL
    Compr Ther; 1981 May; 7(5):3-4. PubMed ID: 7016423
    [No Abstract]   [Full Text] [Related]  

  • 40. Measurement of Cardiac Angiotensin II by Immunoassays, HPLC-Chip/Mass Spectrometry, and Functional Assays.
    De Mello WC; Gerena Y
    Methods Mol Biol; 2017; 1527():127-137. PubMed ID: 28116712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.